HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruofan Zhu Selected Research

TM 1

2/2022Incidence and risk factors for venous thromboembolism during an acute attack in patients with neuromyelitis optica spectrum disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruofan Zhu Research Topics

Disease

2Neuromyelitis Optica (Devic's Disease)
01/2022 - 09/2021
1Transverse Myelitis (Necrotizing Myelitis)
02/2022

Drug/Important Bio-Agent (IBA)

1TM 1IBA
02/2022
1Rituximab (Mabthera)FDA Link
01/2022
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2022
1Intravenous Immunoglobulins (IVIG)FDA Link
09/2021